Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

MASK vs SBLX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBLX Captures Overall Composite Edge (65.5 BUY vs 36.0 SELL), While MASK Leads 5–0 on Growth & Valuation Pillars

SBLX Overall Winner 6-Pillar Tally: MASK 5 – 0 SBLX (1 Tie) Matrix Metrics: MASK 3 – 4 SBLX

As of Nov 20, 2026, StableX Technologies, Inc. (SBLX) captures the overall head-to-head institutional edge over 3 E Network Technology Group Ltd Class A (MASK) on higher Unified Composite conviction (65.5/100 BUY vs. 36.0/100 SELL) after splitting the core matrix 4–3 (led by composite factor balance), while MASK wins 5–0 across the 6-pillar growth and valuation breakdown. MASK trades at $1.56 (N/M Forward P/E, 3.6% operating margin) versus SBLX at $3.10 (N/M Forward P/E, 0.0% operating margin).

  • Growth vs. Quality Trade-Off: SBLX earns the overall head-to-head edge with a stronger Unified Composite Score (65.5/100 BUY vs. MASK 36.0/100 SELL) and 3.68β · 114% Vol risk profile, whereas MASK leads top-line expansion (+13.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MASK vs SBLX
MASK NASDAQ
3 E Network Technology Group Ltd Class A Ordinary Shares
Services-Computer Programming Services
$1.56
-3.11% 1D
Market Cap $2.1M
TTM Revenue $7.2M
Forward P/E N/M
Beta / 30D Vol 0.56β · 876% Vol
Unified Composite Score
36.0 / 100 SELL
Tech 15.0 Fund 33.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.7% over 20 days), RSI 51
RSI-14: 51.5 · SMA20: $1.60 · SMA50: $1.17
SBLX NASDAQ Head-to-Head Winner
StableX Technologies, Inc. Common Stock
Communications Services, Nec
$3.10
+23.51% 1D
Market Cap $3.7M
TTM Revenue $5,426
Forward P/E N/M
Beta / 30D Vol 3.68β · 114% Vol
Unified Composite Score
65.5 / 100 BUY
Tech 60.0 Fund 58.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 67
RSI-14: 67.4 · SMA20: $2.38 · SMA50: $2.42

6-Pillar Scorecard Institutional Category Breakdown (MASK 5 – 0 SBLX)

Columns: Metric · MASK · SBLX
1. Valuation Multiples MASK
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.3x 113.4x
2. Growth & Scale MASK
Revenue Growth (YoY) +13.8% +0.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $7.2M $5,426
Market Cap $2.1M $3.7M
3. Profitability & Quality MASK
Gross Margin 47.0% N/A
Operating Margin 3.6% 0.0%
Net Profit Margin -2.7% 0.0%
Return on Equity (ROE) -2.1% -191.9%
4. Balance Sheet & Cash Flow MASK
Cash Generation (TTM) $870,655 EBITDA -$7.3M
Cash Flow Margin 12.1% EBITDA Mgn N/A
Net Cash / Leverage $4.33 Book/Sh · -2.1% ROE $3.0M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat MASK
OpEx & R&D Intensity 43.4% of Rev ($3.1M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Application Operator Auto Manufacturers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MASK (3) vs SBLX (4)
Institutional Metric MASK SBLX Criterion Row Edge
Market Capitalization
Scale
$2.1M $3.7M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+13.8% +0.0% Higher Growth MASK
Operating Margin (TTM)
Profitability
3.6% 0.0% Higher Margin MASK
Net Profit Margin
Profitability
-2.7% 0.0% Higher Margin SBLX
Return on Equity (ROE)
Capital Efficiency
-2.1% -191.9% Higher ROE MASK
52-Week Range Position
Momentum
21% ($0–$7) 27% ($0–$11) Stronger Trend SBLX
Beta / 30D Volatility
Risk Regime
0.56β · 876% Vol 3.68β · 114% Vol Lower Realized Risk SBLX
Unified Institutional Score
Composite Signal
36.0 / 100 (SELL) 65.5 / 100 (BUY) Higher Composite SBLX
Trailing 12M Revenue (USD)
Operating Scale
$7.2M $5,426 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.3x EV/Rev N/M PEG · 113.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$870,655 EBITDA ($4.33 Book/Sh · -2.1% ROE) -$7.3M ($3.0M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBLX +47.5 pp
MASK: +21.9% · SBLX: +69.4%
3M Horizon MASK +614.55 pp
MASK: +622.94% · SBLX: +8.39%
6M Horizon MASK +221.26 pp
MASK: +245.76% · SBLX: +24.5%
1Y Horizon MASK +221.26 pp
MASK: +245.76% · SBLX: +24.5%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MASK vs SBLX. Trailing 12-month operating profitability (MASK 3.6% vs SBLX 0.0%) and valuation multiples (MASK N/M vs SBLX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MASK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$7.2M
Gross Margin47.0%
Op. Margin3.6%
ROE / Fwd P/E-2.1% · N/M
SBLX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5,426
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-191.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MASK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MASK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SBLX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SBLX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MASK Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $2.1M market capitalization and 3.6% operating margin.
OpEx & R&D Reinvestment 43.4% of Rev ($3.1M)
90D Engineering Disclosures 0 Published
SBLX Moat Profile Cyclical / Execution-Driven Positioning
Auto Manufacturers Operator
Competes within the Auto Manufacturers value chain with $3.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MASK vs SBLX Key Questions & Quantitative Answers

As of Nov 20, 2026, StableX Technologies, Inc. (SBLX) captures the overall head-to-head institutional edge over 3 E Network Technology Group Ltd Class A (MASK) on higher Unified Composite conviction (65.5/100 BUY vs. 36.0/100 SELL) after splitting the core matrix 4–3 (led by composite factor balance), while MASK wins 5–0 across the 6-pillar growth and valuation breakdown. MASK trades at $1.56 (N/M Forward P/E, 3.6% operating margin) versus SBLX at $3.10 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: SBLX earns the overall head-to-head edge with a stronger Unified Composite Score (65.5/100 BUY vs. MASK 36.0/100 SELL) and 3.68β · 114% Vol risk profile, whereas MASK leads top-line expansion (+13.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

MASK leads the Growth & Scale pillar: MASK posts +13.8% YoY revenue growth and +0.0% YoY earnings growth on $7.2M TTM revenue (47.0% gross margin, 3.6% operating margin), compared with SBLX at +0.0% YoY revenue growth and +0.0% YoY earnings growth on $5,426 TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, MASK generates $7.2M in USD-normalized revenue versus $5,426 for SBLX. In operating R&D and SG&A reinvestment, MASK deploys 43.4% of Rev ($3.1M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SBLX.

MASK screens cheaper on headline valuation multiples. MASK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.3x EV/Revenue (12.1% EBITDA margin), whereas SBLX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 113.4x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MASK (-2.1% ROE) versus SBLX (-191.9% ROE) capital efficiency.

In options market volatility and institutional positioning, MASK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.56β · 876% Vol realized risk). By comparison, SBLX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.68β · 114% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.